|1.||Myhrer, Trond: 13 articles (09/2015 - 06/2003)|
|2.||Aas, Pål: 11 articles (09/2015 - 06/2003)|
|3.||Enger, Siri: 8 articles (09/2015 - 02/2006)|
|4.||Mariussen, Espen: 3 articles (09/2015 - 10/2013)|
|5.||Hur, Gyeung-Haeng: 3 articles (01/2012 - 01/2002)|
|6.||Kim, Yun-Bae: 3 articles (11/2005 - 01/2002)|
|7.||Galea, Adrian: 3 articles (12/2003 - 04/2002)|
|8.||Taylor, David: 3 articles (12/2003 - 04/2002)|
|9.||Sharma, Tonmoy: 3 articles (12/2003 - 04/2002)|
|10.||Kumari, Veena: 3 articles (12/2003 - 04/2002)|
12/15/2013 - "When used as prophylactic therapies, both regimens protected equally well against seizures, but only the procyclidine regimen provided neuroprotection. "
12/15/2013 - "When the treatments were administered 10 and 14 or 20 and 24 min after soman exposure, only the procyclidine regimen was able to terminate seizures and preserve lives. "
02/01/2008 - "The results showed that only procyclidine (6 microg) and caramiphen (10 microg) antagonized soman-induced seizures. "
04/15/2007 - "The combination of donepezil and procyclidine protects against soman-induced seizures in rats."
05/01/2004 - "Physostigmine (0.1 mg/kg) and procyclidine in a dose of 1 mg/kg did not prevent convulsions or seizures when the soman dose was 1.6 x LD50. "
|2.||Schizophrenia (Dementia Praecox)
12/01/2003 - "These findings indicate that acute administration of a clinically relevant dose of procyclidine leads to mild impairments in eye movement performance in schizophrenic patients, suggesting the need to consider this compound in oculomotor studies in schizophrenia. "
03/01/2003 - "Effects of acute procyclidine administration on prepulse inhibition of the startle response in schizophrenia: a double-blind, placebo-controlled study."
12/01/2003 - "Effects of procyclidine on eye movements in schizophrenia."
06/01/2002 - "Further investigations are required to quantify the effects of procyclidine on CFFT and cardiac function in patients with schizophrenia."
04/01/2002 - "Effects of oral procyclidine administration on cognitive functions in healthy subjects: implications for schizophrenia."
09/01/2015 - "Supralethal poisoning by any of the classical nerve agents is effectively counteracted by procyclidine regimens in rats."
01/01/2002 - "The antidotal, anticonvulsant and neuroprotective effects of physostigmine (PhS) and procyclidine (PC), the combinational prophylactics for organophosphate poisoning, were evaluated. "
01/01/1998 - "Effectiveness of procyclidine in combination with carbamate prophylactics against diisopropylfluorophosphate poisoning."
11/28/2004 - "Taken together, it is suggested that the combination of physostigmine and procyclidine, at adequate doses, could be a choice to provide the victims of organophosphate poisoning with chance of intensive care for survival and neuroprotection."
11/28/2004 - "Protection by sustained release of physostigmine and procyclidine of soman poisoning in rats."
|4.||Neuralgia (Stump Neuralgia)
05/01/2003 - "In the present study, we used a sciatic nerve ligation model that produces a hyperalgesic (neuropathic pain) state in adult rats to evaluate the ability of procyclidine or ethopropazine, either alone or in combination with an alpha(2) adrenergic agonist, to ameliorate neuropathic pain. "
05/01/2003 - "We found that both procyclidine and ethopropazine alleviated thermal hyperalgesia in a dose dependent manner; when a marginally effective dose of these agents was combined with an ineffective dose of an alpha(2) adrenergic agonist (clonidine or guanabenz), the combination therapy provided effective and long-lasting relief from neuropathic pain. "
|5.||Depressive Disorder (Melancholia)
|4.||HI 6 (H16)
|7.||2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)
|10.||Adrenergic Agonists (Adrenergic Receptor Agonist)
|4.||Deep Brain Stimulation
|5.||Intensive Care (Surgical Intensive Care)